You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HR-NB

Showing 1 - 25 of 1,710
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

Terminated
  • Neuroblastoma
  • antibody ch14.18
  • +4 more
  • Cologne, Germany
    University of Cologne
Nov 3, 2022

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

Active, not recruiting
  • Neuroblastoma
  • Hu3F8
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 1, 2022

Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)

Not yet recruiting
  • Neuroblastoma
  • Anti Thymocyte Globulin
  • +10 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022

Neuroblastoma, High-risk Neuroblastoma, Metastatic Neuroblastoma Trial in United States (OPT-821 (QS-21), oral ß-glucan)

Recruiting
  • Neuroblastoma
  • +2 more
  • OPT-821 (QS-21)
  • oral β-glucan
  • Basking Ridge, New Jersey
  • +6 more
Sep 21, 2023

Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

Recruiting
  • Neuroblastoma
  • Ganglioneuroblastoma
  • monoclonal antibodies GD2
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023

Therapeutic Position, Hemodynamics Trial in Belém (THERAPEUTIC POSITIONS)

Completed
  • Therapeutic Position
  • Hemodynamics
  • THERAPEUTIC POSITIONS
  • Belém, Pará, Brazil
    Paulo Eduardo Santos Avila
Dec 1, 2021

Vitiligo Trial in Los Angeles (Afamelanotide and NB-UVB Light, NB-UVB Light)

Recruiting
  • Vitiligo
  • Afamelanotide and NB-UVB Light
  • NB-UVB Light
  • Los Angeles, California
    Clinuvel investigational site
Oct 25, 2023

Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)

Active, not recruiting
  • Neuroblastoma
  • Hu3F8 With GM-CSF
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 2, 2022

Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)

Not yet recruiting
  • Obesity
  • Naltrexone-Bupropion (NB) Combination
  • Placebo
  • (no location specified)
Oct 18, 2023

Binge-Eating Disorder, Obesity Trial in New Haven (Naltrexone and Bupropion, Placebo)

Recruiting
  • Binge-Eating Disorder
  • Obesity
  • Naltrexone and Bupropion
  • Placebo
  • New Haven, Connecticut
    Yale Department of Psychiatry
Dec 21, 2022

Apnea of Newborn, Preterm Labor Trial in Santiago (No intervention, scare ventilator at 20, scare ventilator at 40)

Completed
  • Apnea of Newborn
  • Preterm Labor
  • No intervention
  • +2 more
  • Santiago, Area Metropolitana, Chile
    Puc, Nicu
Sep 16, 2022

Atopic Dermatitis Eczema, Atopic Dermatitis Trial (NB-UVB phototherapy, Optimal topical therapy)

Not yet recruiting
  • Atopic Dermatitis Eczema
  • Atopic Dermatitis
  • NB-UVB phototherapy
  • Optimal topical therapy
  • (no location specified)
Jan 19, 2023

Learning, Humans, Consolidation Trial in Philadelphia (Associative inference, Category learning, Sleep)

Recruiting
  • Learning
  • +3 more
  • Associative inference
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jun 12, 2023

Vitiligo, Dermatology/Skin - Other Trial in Baltimore (Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet)

Active, not recruiting
  • Vitiligo
  • Dermatology/Skin - Other
  • Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet
  • Baltimore, Maryland
    Johns Hopkins Outpatient Center
Jun 28, 2022

Embolic Stroke of Undetermined Source, Transient Ischemic Attack, Right-To-Left Atrial Shunt Trial in United States (NeuralBot

Completed
  • Embolic Stroke of Undetermined Source
  • +3 more
  • NeuralBot Investigational System
  • Phoenix, Arizona
  • +6 more
Sep 29, 2022

Parkinson Disease, Gait Analysis, Therapy, Directly Observed Trial (Terazosin)

Not yet recruiting
  • Parkinson Disease
  • +3 more
  • (no location specified)
May 3, 2023

Soluble Programmed Death-1 in Predicting Progression of

Recruiting
  • Nontuberculous Mycobacterial Lung Disease
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jan 18, 2023

    Effect of Material and Technique Trial in Minya (single cone technique using TotalFill BC Sealer, warm vertical compaction

    Completed
    • Effect of Material and Technique
    • single cone technique using TotalFill BC Sealer
    • warm vertical compaction technique using TotalFill BC Sealer HiFlow
    • Minya, Egypt
      Faculty of Oral and dental medicine, Minia University
    Oct 4, 2023

    22q11 Deletion Syndrome Trial in Philadelphia, Seattle, Toronto (NB-001, Placebo)

    Recruiting
    • 22q11 Deletion Syndrome
    • Aurora, Colorado
    • +3 more
    Nov 16, 2022

    Generalized Vitiligo Trial in Detroit (Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy)

    Terminated
    • Generalized Vitiligo
    • Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy
    • Detroit, Michigan
      Department of Dermatology, Henry Ford Medical Center, 3031 West
    Feb 9, 2022

    High-Risk Neuroblastoma Trial in Krakow (Chemoimmunotherapy (Dinutuximab beta in combination with chemo))

    Recruiting
    • High-Risk Neuroblastoma
    • Chemoimmunotherapy (Dinutuximab beta in combination with chemotherapy)
    • Krakow, Malopolska, Poland
      University Children Hospital
    Mar 8, 2022

    Real-World Evidence on Cardiovascular Safety of CONTRAVE® in

    Completed
    • Obesity
      • Brentwood, Tennessee
        Currax Pharmaceuticals
      Oct 17, 2023

      Vitiligo Trial in Nice (Glisodin tablet, Placebo tablet)

      Completed
      • Vitiligo
      • Glisodin tablet
      • Placebo tablet
      • Nice, Alpes-Maritime, France
        Passeron
      Aug 30, 2022

      Vitiligo Trial in United States (ARQ-252 cream 0.3%, ARQ-252 Vehicle cream, NB-UVB phototherapy active treatment)

      Terminated
      • Vitiligo
      • ARQ-252 cream 0.3%
      • +3 more
      • San Diego, California
      • +4 more
      Aug 4, 2022